Frank E Uschner Selected Research

Frank E Uschner Research Topics

Disease

16	Fibrosis (Cirrhosis) 12/2023 - 06/2014
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2015
8	Portal Hypertension 10/2023 - 01/2015
6	Liver Diseases (Liver Disease) 01/2022 - 10/2016
6	Inflammation (Inflammations) 01/2021 - 08/2015
5	Ascites 10/2023 - 01/2018
4	Acute-On-Chronic Liver Failure 01/2022 - 03/2019
3	Infections 10/2023 - 01/2021
2	Hemorrhage 10/2023 - 01/2021
2	Weight Loss (Weight Reduction) 01/2021 - 08/2015
2	Alcoholic Fatty Liver 01/2021 - 08/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 11/2023
1	Hepatorenal Syndrome 10/2023
1	AIDS-Related Complex (ARC) 01/2021
1	Alcoholic Hepatitis 01/2021
1	Hypoalbuminemia 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Erectile Dysfunction 01/2020
1	End Stage Liver Disease 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2015
1	Hepatomegaly 08/2015
1	Weight Gain 08/2015
1	Neoplasms (Cancer) 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2015

Drug/Important Bio-Agent (IBA)

5	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2020 - 01/2015
4	LigandsIBA 01/2021 - 06/2014
4	Hydroxyproline (4 Hydroxyproline)IBA 01/2021 - 08/2015
3	CytokinesIBA 01/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2021 - 08/2015
2	CholesterolIBA 10/2016 - 08/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2016 - 09/2015
1	SodiumIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2023
1	Neuropeptide YIBA 01/2023
1	Neprilysin (Neutral Endopeptidase)IBA 01/2023
1	ProteomeIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021
1	angiogeninIBA 01/2021
1	CEACAM1 ProteinIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	EnzymesIBA 01/2021
1	oil red OIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	InflammasomesIBA 01/2021
1	C-Type Lectins (C-Type Lectin)IBA 01/2020
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020
1	CC ChemokinesIBA 01/2020
1	Bacterial DNAIBA 01/2019
1	16S Ribosomal RNAIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	Collagen Type III (Type III Collagen)IBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	Complement C3 (C3 Complement)IBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	rho-Associated KinasesIBA 10/2016
1	Atorvastatin (Lipitor)FDA Link 09/2015
1	Choline (Choline Chloride)IBA 08/2015
1	Methionine (L-Methionine)FDA Link 08/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	ApolipoproteinsIBA 08/2015
1	AVE 0991IBA 01/2015
1	Vasoconstrictor AgentsIBA 01/2015
1	AngiotensinsIBA 01/2015
1	Angiotensin IIIBA 01/2015
1	Thioacetamide (Thioacetamid)IBA 01/2015
1	angiotensin I (1-7)IBA 01/2015
1	Monomeric GTP-Binding ProteinsIBA 01/2015
1	tyrosine receptor (receptor, tyrosine)IBA 01/2015
1	Protein Kinase CIBA 01/2015

Therapy/Procedure

6	Ligation 01/2021 - 01/2015
5	Transjugular Intrahepatic Portasystemic Shunt 10/2023 - 01/2021
5	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2023 - 01/2018
4	Liver Transplantation 11/2023 - 01/2015
2	Therapeutics 01/2023 - 01/2021
1	Oral Administration 01/2023
1	Salvage Therapy 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021